Pyrimidine-2,4,6-triones:: A new effective and selective class of matrix metalloproteinase inhibitors

被引:123
|
作者
Grams, F [1 ]
Brandstetter, H
D'Alò, S
Geppert, D
Krell, HW
Leinert, H
Livi, V
Menta, E
Oliva, A
Zimmermann, G
机构
[1] Hoffmann La Roche Ag, Preclin Res Pharma, Discovery Technol, CH-4070 Basel, Switzerland
[2] Max Planck Inst Biochem, D-82152 Martinsried, Germany
[3] Novuspharma SpA, Chem Res, I-20052 Monza, Italy
[4] Roche Diagnost GMBH, Biol Res, D-82377 Penzberg, Germany
[5] Roche Diagnost GMBH, Chem Res, D-68305 Mannheim, Germany
关键词
barbiturate; cancer; drug design; gelatinase; inhibitor; matrix metalloproteinase;
D O I
10.1515/BC.2001.159
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases that have been implicated in various disease processes. Different classes of MMP inhibitors, including hydroxamic acids, phosphinic acids and thiols, have been previously described. Most of these mimic peptides and most likely bind in a similar way to the corresponding peptide substrates. Here we desccribe pyrimidine-triones as a completely new class of metalloprotease inhibitors. While the pyrimidine-trione template is used as the zinc-chelating moiety, the substituents have been optimized to yield inhibitors comparable in their inhibition efficiency of matrix metalloproteinases to hydroxamic acid derivatives such as batimastat. However, they are much more specific for a small subgroup of MMPs, namely the gelatinases (MMP-2 and MMP-9).
引用
收藏
页码:1277 / 1285
页数:9
相关论文
共 50 条
  • [41] Heterocyclization of 5-(Arylmethylidene)pyrimidine-2,4,6(1H,3H,5H)-triones with Arenecarbaldehyde Oximes in the Presence of N-Bromosuccinimide and Triethylamine
    A. G. Tyrkov
    E. A. Yurtaeva
    Russian Journal of Organic Chemistry, 2019, 55 : 978 - 982
  • [42] Application and details of photoinduced oxidative cyclization of 5-(4′,9′-methanocycloundeca-2′,4′,6′,8′,10′-pentaenylidene)-pyrimidine-2,4,6(1,3,5H)-triones and related compounds
    Naya, Shin-Ichi
    Yamaguchi, Yohei
    Nitta, Makoto
    TETRAHEDRON, 2008, 64 (14) : 3225 - 3231
  • [43] A convenient one-pot synthesis of asymmetric 1,3,5-triazine-2,4,6-triones and its application towards a novel class of gonadotropin-releasing hormone receptor antagonists
    Guo, ZQ
    Wu, DP
    Zhu, YF
    Tucci, FC
    Pontillo, J
    Saunders, J
    Xie, Q
    Struthers, RS
    Chen, C
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 693 - 698
  • [44] Three-Component Heterocyclization of 5-(Arylmethylidene)pyrimidine-2,4,6(1H,3H,5H)-triones with Isoquinoline and Dimethyl But-2-ynedioate
    Tyrkov, A. G.
    Yurtaeva, E. A.
    RUSSIAN JOURNAL OF ORGANIC CHEMISTRY, 2024, 60 (04) : 645 - 649
  • [45] Triaryl-1,3,5-triazinane-2,4,6-triones functionalized with electron-rich Fe(II) and Ru(II) acetylide complexes: new organometallic octupoles with large hyperpolarizabilities
    Trujillo, Alexander
    Veillard, Romain
    Argouarch, Gilles
    Roisnel, Thierry
    Singh, Anu
    Ledoux, Isabelle
    Paul, Frederic
    DALTON TRANSACTIONS, 2012, 41 (25) : 7454 - 7456
  • [46] Efficient Synthesis of New Pyrimido[5′,4′:5,6]pyrano[2,3-d]pyrimidine-2,4,6(1H,3H)-triones via the Tandem Intramolecular Pinner–Dimroth Rearrangement, and Their Antibacterial Activity
    M. Asadian
    A. Davoodnia
    S. A. Beyramabadi
    Russian Journal of General Chemistry, 2018, 88 : 2658 - 2663
  • [47] Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines
    Natchus, MG
    Bookland, RG
    De, B
    Almstead, NG
    Pikul, S
    Janusz, MJ
    Heitmeyer, SA
    Hookfin, EB
    Hsieh, LC
    Dowty, ME
    Dietsch, CR
    Patel, VS
    Garver, SM
    Gu, F
    Pokross, ME
    Mieling, GE
    Baker, TR
    Foltz, DJ
    Peng, SX
    Bornes, DM
    Strojnowski, MJ
    Taiwo, YO
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) : 4948 - 4963
  • [48] Design, synthesis, and discovery of 5-((1,3-diphenyl-1H-pyrazol-4-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones and related derivatives as novel inhibitors of mPGES-1
    Ding, Kai
    Zhou, Ziyuan
    Zhou, Shuo
    Yuan, Yaxia
    Kim, Kyungbo
    Zhang, Ting
    Zheng, Xirong
    Zheng, Fang
    Zhan, Chang-Guo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (05) : 858 - 862
  • [49] Discovery of novel 6,7-disubstituted-4-phenoxyquinoline derivatives bearing 5-(aminomethylene)pyrimidine-2,4,6-trione moiety as c-Met kinase inhibitors
    Tang, Qidong
    Zhang, Guogang
    Du, Xinming
    Zhu, Wufu
    Li, Ruijuan
    Lin, Huafang
    Li, Pengcheng
    Cheng, Maosheng
    Gong, Ping
    Zhao, Yanfang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (04) : 1236 - 1249
  • [50] Phenylamino-pyrimidine (PAP) derivatives: A new class of potent and selective inhibitors of protein kinase C (PKC)
    Zimmermann, J
    Caravatti, G
    Mett, H
    Meyer, T
    Muller, M
    Lydon, NB
    Fabbro, D
    ARCHIV DER PHARMAZIE, 1996, 329 (07) : 371 - 376